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Summary
Objective: Many factors are involved in the osteoarthritic process. It is not yet known which are initiators, promoters or simply results. Thus,
we have evaluated some of those potentially important factors in osteoarthritis (OA) as observed sequentially for the first time in synovial
fluids.
Design: Synovial fluids (SF) obtained between 1992–2002 were all routinely evaluated for gross appearance, leukocyte counts and
microscopic examination of wet drop preparations. We used regular and polarized light and alizarin red s stains. We separated out all OA
patients, then we looked for patients who had more than two synovial fluid analyses to get sequential information. Time between first and final
aspiration ranged from 2 to 7 (3.6±1.6) years and number of analyses per patients from 3 to 6 (3.3±0.7). We related synovial fluid crystals,
fibrils and white blood cell count (WBC) to age, sex, disease duration and radiographic assessment according to the Kellgren–Lawrence
radiographic rating system.
Results: Of 4523 synovial fluid examinations, we found 855 in patients with knee OA; 330 patients with adequate clinical details for
comparison were included in our study. Twenty-six patients (one woman and 25 men) had sequentially examined SF.
We found that 52% of those OA patients with effusions studied had crystals identified in their synovial fluid. Twenty-one percent of all the
patients had CPPD crystals, 47% had hydroxyapatite, also called basic calcium phosphate (BCP) crystals and 16% had both types of
crystals. Microscopically identifiable fibrils were found in 60% of SF.
In sequentially examined patients, CPPD crystals and apatite (BCP) were found in 19% and 23%, respectively, at the first aspiration and,
in 34% and 58% at the final aspiration. Fibrils were seen in 54% at first examination and 85% later. Apatite and fibrils showed more significant
correlation with time (r=0.51, r=0.92) than did CPPD (r=0.32). SF WBC correlated only with CPPD crystals and did not increase with OA
duration or severity. CPPD, apatite and fibrils all correlated with higher radiographic grades of OA.
Conclusions: As noted before CPPD and apatite crystals were more common in patients with more severe OA. New findings are that our
sequential cases showed that there were some patients with no crystals at onset but that crystals appeared with progression of the disease.
Fibril presence in SF also correlated with progression of the disease. © 2003 OsteoArthritis Research Society International. Published by
Elsevier Science Ltd. All rights reserved.
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Osteoarthritis (OA) is a well-known disease since the
Egyptian mummies, and is in part an aging process and
one of the most common diseases1. However, much of
our knowledge about its pathogenesis was formed in the
last part of the twentieth century. There is now strong
evidence that many factors ranging from the mechanical to
biochemical and genetic join that process1,2.
OA is characterized by degeneration of the cartilage with
associated changes in bone. There is usually a mild degree
of synovial inflammation, and calcium pyrophosphate or
apatite crystals are often present3–6. The end pathological
process in OA is an imbalance between joint cartilage
synthesis and degradation resulting in cartilage loss. The
crystals have a still undefined role in this process7,8. When50one looks at SF in advanced OA, one or both crystals are
seen in high percentages. These crystals were found in up
to 60% of all patients with knee effusions in OA and 100%
of small group of patients with grade-4 OA4. In destructive
OA at a large joint such as the Milwaukee shoulder syn-
drome, calcium crystals are also seen in 100% of patients9.
Calcium containing crystals may follow or precede destruc-
tive joint changes7. Crystals, whether primary or secondary
to tissue degeneration, may accelerate the osteoarthritic
process10,11.
Fibrils, described in synovial fluid by Hollander in 196012,
are a neglected microscopic finding. Using phase contrast
microscopy, Kitridou et al. found fibrils in most synovial
fluids and, showed that some of these fibrillar structures are
indeed collagen fibers13. Presumably these are products of
the core collagenous structure of cartilage14,15. One might
expect a correlation between these fibrils and severity of
OA but this has not been examined.
The objective of this study was to investigate the fre-
quency and timing of appearance of calcium pyrophos-
phate dihydrate (CPPD) and apatite crystals and fibrils inRecieved 29 July 2002; revision accepted 9 October 2002.
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promoters or both?STATISTICAL ANALYSIS
All data are expressed as the mean±S.D. Paired samples
were analysed using Mann–Whitney U or Wilcoxon-rank
tests for matched pairs when they were needed. LinearFig. 1. Schema of study.Fig. 2. Graphical documentation of results for the crystals.Table I
General characteristics of the patients
Total
(n=330)
Female
(n=46)
Male
(n=284)
Age (year) 65.22±11.85 61.02±13.81 65.9±11.39
X-ray grade
(0–4)
2.63±1.19 2.17±1.25 2.7±1.17
SF WBC
(×103/ml)
174.92±172.66 154.76±168.49 176.08±169.98
Fibrils 197 (60%) 21 (46%) 176 (62%)
CPPD 70 (21%) 12 (26%) 58 (20%)
Apatite 155 (47%) 17 (37%) 138 (49%)
Apatite+
CPPD
54 (16%) 10 (22%) 44 (15%)Table II
Statistical comparison of some variables among OA patients
P values
X-ray grade Fibrils Apatite
CPPD
crystals
Age (year) 0.0001 0.93 0.1 0.017
WBC (×103/ml) 0.13 0.83 0.5 0.01
Fibrils 0.0005 — 0.35 0.13
CPPD crystals 0.004 0.13 0.0001 —
Apatite 0.005 0.35 — 0.0001
X-ray grade (0–4) — 0.0005 0.005 0.004PATIENTS AND MATERIALS
We evaluated all synovial fluid analysis reports on speci-
mens obtained between 1992 and 2002 at the Philadelphia
VA Medical Center and identified those from knee OA
patients (Fig. 1), diagnosed according to American College
of Rheumatology criteria based on both clinical and radio-
logical evidence16,17. Patients with other rheumatic dis-
eases that affect knees (particuarly rheumatoid arthritis and
gout) were excluded. We recorded synovial fluid results,
age, sex and radiographic assessment from computerizedrecords of patients’ archives. Radiographic grading of knee
films was by the Kellgren–Lawrence radiographic rating
system18.
Finally, we recorded patients whose SF had been
re-examined more than two times to get sequential infor-
mation about relations between the crystals, fibrils, WBC
and the disease process. Time between first and final
aspiration ranged from 2 to 7 (3.6±1.6) years and number
of analyses from 3 to 6 years (3.3±0.7).
Synovial fluid (SF) analyses for crystals had been per-
formed by examination of wet drop preparations of SF
under regular and polarized light19. CPPD crystals were
considered present when crystals of rhomboid shape with
weak positive birefringence were observed. Apatite crystals
were suspected by presence of glossy non-birefringent
chunks staining positively with alizarin red s and recorded
as 0–3+19,20. We accepted all with 1+ and more as
positive. Fibrils were considered present when clumps
were seen in at least two high power fields in wet drop
preparations13,19,21.
52 S. Nalbant et al.: Synovial fluid features in osteoarthritisregression analysis was used for sequential patients to
examine the relatonship of duration with fibrils, CPPD and
apatite crystals. P values less than 0.05 were considered
significant.Discussion
Compared to the literature, our percentage of SF with
crystals in OA (52%) was in the middle of the reported
range of 41% to 60%4,5. Some of the variation in that range
may be due to different techniques used. Our study also
gives very similar results to the previously reported results
on the relation of calcium containing crystals to OA
severity22–24. The correlation between crystal frequency
and higher radiologic grade of OA would be consistent
either with the thesis that the crystals contribute to the
severity, or that crystal presence results from more severe
disease4.
Our important finding is the first documentation that OA
patients who did not have CPPD or apatite crystals on the
first synovial fluid studied had these crystals detected later.
This strongly supports that some crystals are a result of the
OA process. In one previous retrospective sequential study,
Reuge and co-workers25 identified that 25% of 44 OA
patients who initially had no radiographic evidence of joint
calcification developed either X-ray evidence of calcifi-
cation or CPPD crystals in SF over a mean of 8 years. NotFig. 3. Fibrils in synovial fluid (ordinary light, ×300) are long strands with a ragged and angulated appearance. This appearance distinguishes
them from crystals.Table III
Synovial fluid findings on sequential visits
First visit Last visit P
CPPD 19% (5/26) 34% (9/26) 0.046
Apatite 23% (6/26) 58% (15/26) 0.005
Fibril 54% (14/26) 85% (22/26) 0.005Results
As shown in Fig. 1, 855 of 4523 synovial fluid examin-
ation reports were on OA fluids. Of the 855 patients with
knee osteoarthritis, 330 patients were included to our
study because others had missing data or they also had
some other rheumatologic diseases. Only 26 patients
(one woman and 25 men) were accepted as sequentially
examined patients (Fig. 1).
We found 52% (171/330) of the OA patients had crystals
identified in their synovial fluid. Twenty-one percent of all
the patients with crystals had CPPD crystals, 47% had
apatites and 16% had both types of crystals (Table I, Fig.
2). Fibrils were found in 60% of patients (Fig. 3).
Table II summarizes the correlations among the vari-
ables examined. OA patients with older ages were associ-
ated with increased frequency of CPPD crystals and higher
radiographic grades (P=0.0001). However, synovial fluid
WBC was correlated only with CPPD crystals (P=0.01).
Fibrils, CPPD crystals and apatite crystals were all corre-
lated with higher radiographic grades of OA (P<0.05).CPPD and BCP were significantly encountered together
(P=0.0001).
In sequentially examined patients, CPPD and apatites
were present in 19% and 23% respectively at the first visit
and in 34% and 58% at the last visit. Fibrils were seen in
54% at the beginning and in 85% later (Table III). The
difference of frequencies between first and last visits for
CPPD, apatite and fibrils were significant (P<0.05) (Table
III). The frequencies of the development of CPPD, apatite
and fibrils in knee joints of OA patients initially found
negative for these variables were 15%, 35% and 31%
respectively. Apatite crystals and fibrils showed more sig-
nificant correlation with duration in sequential examinations
(r=0.51, r=0.92) than CPPD did (r=0.32).
Osteoarthritis and Cartilage, Vol. 11, No. 1 53all had SF examinations and apatites (BCP) were not
considered. We found that about 15% of our cases with SF
without CPPD later developed the crystals while 31%
developed apatites.
It is known that the prevalence of CPPD crystal depo-
sition in the knee increases with age26–28, CPPD presence
also correlated with age in our study. In contrast, apatite
presence correlated only with OA severity by X-ray.
A striking finding in our study was the very significant
correlation of fibrils with radiologic stage of OA (P=0.005).
Fibrils as defined in our analyses were found in 60% of OA
fluids and showed correlation with duration of the disease
but not with age (P=0.93). Thus SF fibrils may be an
independent consequence of some pathologic events in
the OA process.
Birefringent fibril strands that are morphologically indis-
tinguishable from sloughed collagen fibers may be visual-
ized on wet mount microscopy (Fig. 3)19. It is impossible,
however, to be certain that all fibrils seen in a wet smear of
synovial fluid under phase contrast or polarized light
microscopy are indeed collagen. Fresh fibrin, for instance,
may not be easily distinguished from collagen fibrils12.
Swann noted collagen fibers as an incidental finding during
an electron microscopic study of SF29. On the other hand,
Cheung et al. using gel electrophoresis and spectro-
photometry also showed that the presence of collagen
(about 5 g or more) was correlated with roentgenographic
evidence of joint space narrowing in OA and other arthropa-
thies30. Fibrils in our study correlated highly with radio-
graphic OA but not with CPPD or apatites. More study is
needed to characterize fibrils and collagen in SF as poss-
ible factors in pathogenesis. Other techniques to quantify
collagen in SF will be of interest31.
It is generally agreed that there is evidence for the
presence of a mild synovitis in OA joints32–34. In our study
inflammation was evaluated with SF WBC, which had a
correlation only with CPPD presence. Our SF WBC did not
correlate with apatite presence. SF WBC probably does not
reflect all synovial tissue changes.
Male dominance in our VA hospital population may limit
for generalizability of the results. However, we know of no
studies suggesting different patterns of crystal deposition in
males vs females.
This study has confirmed that fibrils, CPPD and apatite
crystals are found in SF in the osteoarthritic process. Also,
we sequentially showed that there were some patients with
no crystals and no fibrils at onset but they appeared with
progression of the disease. The role(s) of these materials in
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